Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Adela, Inc.

Adela, Inc.

Stage unknownFoster City, CAadelabio.comBiotechnology
Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
3 rounds
  1. Oct 10, 2023
    Form D equity offering · $3.3M (form d sold) · 3 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Adela, Inc. filed Form D: $3,296,554 sold of $3,296,554, Biotechnology”
  2. Jul 28, 2023
    Form D equity offering · $48.5M (form d sold) · 11 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Adela, Inc. filed Form D/A: $48,540,780 sold of $49,317,173, Biotechnology”
  3. Jul 14, 2021
    Form D equity offering · $1.2M (form d sold) · 2 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Adela, Inc. filed Form D: $1,187,700 sold of $1,187,700, Biotechnology”
Investors on record
1 edges
People
7 officers, 5 directors
Timeline
3
  1. Jul 29, 2024
    Adela, Inc. filed Form D/A: $48,540,780 sold of $49,317,173, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Feb 14, 2024
    Adela, Inc. filed Form D: $3,296,554 sold of $3,296,554, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Feb 14, 2024
    Adela, Inc. filed Form D: $1,187,700 sold of $1,187,700, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
36 observations
Every observation on this company